Deliberate release into the
environment of GMOs for any other purposes than placing on the
market:
Field experimentation of a genetically
modified maize. Functional validation of a gene involved in
nitrogen efficiency and grain filling - Biogemma |
Date of publication: January 27,
2005
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification
report
General information
Notification Number: B/FR/05/01.01
Member State:France
Date of Acknowledgement:10/12/2004
Title of the Project:
Field experimentation of a genetically modified maize.
Functional validation of a gene involved in nitrogen efficiency
and grain filling.
Proposed period of release From:01/04/2005
To:30/11/2008
Name of the Institute(s) or Company(ies): Biogemma;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
Yes
If yes, notification number(s):
B/FR/03/02/04
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
hybrids between A188 and a breeding line
|
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
Better nitrogen assimilation by the plant, increase of
essential amino acid content in the grain.
Transgenic plants contain either the bar gene conferring
resistance to glufosinate or kanamycine, respectively.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
Actin1 and first intron: Oryza sativa, non coding regulatory
sequence
CsVMV promoter : Cassava vein mosaic virus, non coding
regulatory sequence
Actin1 first intron: Oryza sativa, non coding regulatory
sequence
Bar (pat) : Streptomyces hygroscopicus, coding sequence
nos 3’ : Agrobacterium tumefaciens, non coding regulatory
sequence
nptII: Escherichia coli, coding sequence
Ds 5’ / Ds 3’: Zea mays, non coding sequence
Gs-1b (Gln1-3): Zea mays, coding sequence
RB / LB: Agrobacterium tumefaciens, non-coding sequence
6. Brief description of the method used for the genetic
modification:
Agrobacterium tumefaciens mediated transformation.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Non applicable
Experimental
Release
1. Purpose of the release:
Production of plant and grain under agronomic conditions.
Total biomass production evaluation under different nitrogen
fertilization conditions. Functional validation of a maize gene.
2. Geographical location of the site:
Center of France (Puy-de-Dôme, Auvergne)
South-west of France (Haute-Garonne, Midi-Pyrénées)
For the first year
3. Size of the site (m2):
Auvergne 1 800 sq mt (2005 to 2008),
Midi-Pyrénées 1 800 sq mt (2005 to 2008),
For each location, the size corresponds to transgenic plants
only, checks and border rows not included)
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Second release for these transformation events, first release
has been destroyed by activists.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
None of the introduced traits has potential effects to modify
the plant persistency in the environment(plants will not be
sprayed with herbicide or antibiotic). There is no wild
relatives of corn in Europe and outcrossing are not possible. In
this experiment, there is no modification of the direct or
indirect interactions between the modified plants and target or
non-target organisms. There is no expected effects on human
health and on animal health. Plants will not be used as food.
There is no short-term possible effect on specific cultivation
management and harvesting techniques.
Potential environmental impact considered minimal, given the
conditions of the field trial (location, absence pollen
production, presence of 4 rows of non-transgenic maize plants
around the field trial, minimal contacts with fauna and flora,
absence of wild relatives of maize species in the release
areas...).
Brief description of any measures taken for the management of
risks:
Release sites located in intensive agriculture areas.
Collection of seeds, destruction of plant vegetative material.
Monitoring and destruction of volunteers during one year
following the end of experiment.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Non applicable |
|
|
|
